Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)

We accrued 201 patients of adult AML treated with conventional therapy, in morphological remission, and evaluated MRD using sensitive error-corrected next generation sequencing (NGS-MRD) and multiparameter flow cytometry (FCM-MRD) at the end of induction (PI) and consolidation (PC). Nearly 71% of pa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Leukemia
Egile Nagusiak: Patkar, Nikhil, Kakirde, Chinmayee, Shaikh, Anam Fatima, Salve, Rakhi, Bhanshe, Prasanna, Chatterjee, Gaurav, Rajpal, Sweta, Joshi, Swapnali, Chaudhary, Shruti, Kodgule, Rohan, Ghoghale, Sitaram, Deshpande, Nilesh, Shetty, Dhanalaxmi, Khizer, Syed Hasan, Jain, Hasmukh, Bagal, Bhausaheb, Menon, Hari, Khattry, Navin, Sengar, Manju, Tembhare, Prashant, Subramanian, Papagudi, Gujral, Sumeet
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102181/
https://ncbi.nlm.nih.gov/pubmed/33558666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-021-01131-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak